期刊文献+

注射用头孢曲松钠引起假性胆结石27例临床分析 被引量:4

下载PDF
导出
摘要 资料与方法 本院2004年至今共发现27例患者因输注头孢曲松钠发生假性胆结石,年龄10472岁。多囚呼吸道感染、尿路感染、外伤感染、腹部感染性疾病发作来院就诊,输注头孢曲松钠,成人用量2g/d,儿童20~80mg/d,1次/d,均以0.9%氯化钠注射液稀释,静滴,疗程5~10天:既往均无胆结石病史,肝肾功能均正常。
作者 杨莉
出处 《中国社区医师》 2008年第19期25-25,共1页 Chinese Community Doctors
  • 相关文献

参考文献4

  • 1王永清.头孢曲松钠导致小儿假性胆石症一例[J].中华儿科杂志,2005,43(4):251-251. 被引量:20
  • 2Boro, Dinleyici EC, Kebapci M, et al. Ceftriaxone, associated biliary sludge and pseudolithiasis during childhood, aprospective study. Pediatr Int, 2004,46 (3): 322.
  • 3Acun C, Erdean L, Sogut A, et al. Gallbladder and urinary tract precipdtations associated with ceftriaxone threapy in children:a prospective study. Ann Trop Pediatr, 2004,24(1):25.
  • 4Biner B, Oner N, Celtik C, et al. Ceftriax- oneassociated biliary pseudolithiasis in children. Jfin Ultrasound, 2006,34(5):217.

二级参考文献6

  • 1Schaad UB, Wedgwood J, Tschaeppeler H. Reversible ceftriaxone-associated biliary pseudolithiasis in children. Lancet, 1988, 2: 1411-1413.
  • 2Prince JS, Senac MO Jr. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child. Pediatr Radiol, 2003,33:648-651.
  • 3Lee SM, Benjamin AL, Teefey SA. Gallbladder sludge and antibiotics. Pediatr Infect Dis J, 1990,9:422-423.
  • 4Palanduz A, Yalcin I, Tonguc E, et al. Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in children. J Clin Ultrasound, 2000,28:166-168.
  • 5Papadopoulou F, Efremidis S, Karyda S, et al. Incidence of ceftriaxone-associated gallbladder pseudolithiasis. Acta Paediatr, 1999,88:1352-1355.
  • 6Bor O, Dinleyici EC, Kebapci M, et al. Ceftriaxone-associated biliary sludge and pseudocholithiasis during childhood: a prospective study. Pediatr Intern, 2004,46:322-324.

共引文献19

同被引文献35

  • 1蒋潇潇.第三代头孢菌素类药物的不良反应与防治[J].中国药房,2004,15(8):495-497. 被引量:54
  • 2王永清.头孢曲松钠导致小儿假性胆石症一例[J].中华儿科杂志,2005,43(4):251-251. 被引量:20
  • 3黄先会,何福果.超声对使用头孢曲松钠及停药后胆囊内沉积物变化的观察[J].中国超声诊断杂志,2006,7(3):222-224. 被引量:16
  • 4郭胜才.阿昔洛韦合用头孢曲松致急性肾功能损害[J].药物不良反应杂志,2006,8(6):455-456. 被引量:8
  • 5Park HZ, Lee SP, Schy AL. Ceftriaxone-associated gallbladder sludge. Identification of calcium-ceftriaxone salt as a major component of gallbladder precipitate. Gastroenterology, 1991, 100 : 1665-1670.
  • 6Schaad UB, Tscheippeler H, Lentze MJ. Transient formation of precipitations in the gallbladder associated with ceftriaxone therapy. Pediatr Infect Dis, 1986, 5 : 708-710.
  • 7Biner B, Oner N, Celtik C, et al. Ceftriaxone-associated biliary pseudolithiasis in children. J Clin Ultrasound, 2006, 34: 217- 222.
  • 8Shiffman ML, Keith FB, Moore EW. Pathogenesis of ceftriaxone- associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubility. Gastroenterology, 1990,99: 1772-1778.
  • 9Xia Y, Lambert KJ, Schteingart CD, et al. Concentrative biliary secretion of ceftriaxone. Inhibition of lipid secretion and precipitation of calcium ceftriaxone in bile. Gastroenterology, 1990, 99: 454-465.
  • 10Arpacik M, Ceran C, Kaya T, et al. Effects of ceftriaxone sodium on in vitro gallbladder contractility in guinea pigs. J Surg Res, 2004, 122: 157-161.

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部